期刊文献+

ROC曲线对比分析超敏cTnT和cTnT对心肌梗死的诊断价值 被引量:1

ROC curves contrast analysis cTnT and cTnT allergic the diagnostic value of myocardial infarction
下载PDF
导出
摘要 目的:通过对心肌梗死与稳定型心绞痛患者绘制超敏肌钙蛋白T(cTnT)和肌钙蛋白T(cTnT)ROC曲线,对比两种方法的优越性。方法:采用电化学免疫发光法测定心梗组、稳定型心绞痛组与健康对照组的血清超敏cTnT和cTnT,并对超敏cTnT和cTnT进行统计学和ROC分析。结果:超敏cTnT在心肌梗死诊断中的敏感度82.6%,特异度92.3%,阳性结果预测值97.9%,诊断临界值0.035ng/ml;cTnT的敏感度78.3%,特异度84.6%,阳性结果预测值94.4%,诊断临界值为0.079ng/ml。超敏cTnT的ROC曲线下面积AUC=0.916,cTnT的AUC=0.856。结论:血清超敏cTnT是诊断急性心肌梗死灵敏而特异的诊断指标,明显优于cTnT,可作为诊断急性心肌梗死的辅助诊断指标,同时能够鉴别心肌梗死和稳定型心绞痛。 Objective: Myocardial infarction in patients with stable angina pectoris draw the ROC curve of high-sensitivity troponin T (cTnT) and troponin T (cTnT), the superiority of the comparison of the two methods. Methods: Electrochemical immunoassay luminescence determination of the MI group, stable angina group and the healthy control group, serum high sensitivity cTnT and cTnT, and high-sensitivity cTnT and eTnT statistics and ROC analysis. Results:Finally ultra sensitive cTnT diagnoses at the cardiac arrest the sensitivity was 82.6 %, the pe culiarity was 92.3 %, the masculine result forecast value was 97.9 %, the diagnosis marginal value was 0. 035ng/ml; The cTnT sensitivity was 78. 3%, the peculiarity was 84.6%, the masculine result forecast value was 94.4%, the diagnosis marginal value was 0. 079ng/ml. Under ultra sensitive cTnT ROC curve area AUC= 0. 916, cTnT AUC = 0. 856% Conclusions: Serum high sensitivity cTnT diagnosis of acute myocardial infarction sensitive and specific diagnostic indicators, significantly better than cTnT can be used as a diagnostic marker in the diagnosis of acute myocardial infarction, at the same time be able to identify myocardial infarction and stable angina pectoris.
出处 《陕西医学杂志》 CAS 2013年第7期902-903,共2页 Shaanxi Medical Journal
关键词 心肌梗死/诊断 心绞痛 稳定型/诊断 肌钙蛋白Ⅰ 肌钙蛋白T@ROC曲线 Myocardial infarction/dignosis Angina, stable/dignosis Troponin I Troponin T@ ROC curve.
  • 相关文献

参考文献6

二级参考文献58

  • 1王前,郑磊,曾方银.超敏C-反应蛋白的研究现状及临床应用[J].中华检验医学杂志,2004,27(8):542-544. 被引量:193
  • 2潘柏申.心脏标志物的临床应用[J].中华检验医学杂志,2005,28(1):124-126. 被引量:62
  • 3[1]Wu A H B. Biochemical markers of cardiac damage: from traditional enzymes to cardiac-specific proteins[J]. Scand J Clin Lab Invest,1999,59(Suppl 230): 74-82.
  • 4[2]Panteghni M, Apple F S, Christenson R H, et al. Proposal from IFCC committee on Standadization of Markers of Cardiac Damage (C-SMCD): recommendation on use of biochemical markers of cardiac damage in acute coronary syndromes [J]. Scand J Clin Lab Invest, 1999,59(Suppl 230): 103-112.
  • 5[3]Wu A H,Apple F S ,Gibler W B, et al. National Academy of Clinical Biochemistry Standards of Laboratory Practice: recommendations for the use of cardiac markers in coronary artery disease[J]. Clin Chem,1999,45: 1104-1121.
  • 6[4]Alpert J S, Thygesen K, Antman E, et al. Myocardial infarction redefined:a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction[J]. J Am Coll Cardiol, 2000,36: 959-969.
  • 7[5]Giri S,Waters D D,Wu A H B. Pathophysiology of acute coronary syndromes In: Card iac markers. Ed. Wu A H B. New Jersey:Humana Press Inc, 1998.21-44.
  • 8[6]Winter R J, Fischer J, Bholasingh R, et al. C-reactive protein and cardiac troponin T in risk stratification:differences in optimal timing of tests early after the onset of chest pain[J]. Clin Chem,2000,46:1597-1603.
  • 9[7]Koenig W, Sund M, Frohlich M, et al. C-reactive protein, a sensitive marker of inflammation, predicts future risk of coronary, heart disease in initial healthy middle-aged men: results from the MONICA Augsburg Cohort Study, 1984 to 1992 [J]. Circulation, 1999, 99:237-242.
  • 10[8]Zimmerman J, Fromm R, Meyer D, et al. Diagnostic marker cooperative study for the diagnosis of myocardial infarction [J].Circulation, 1999,99: 1671-1677.

共引文献188

同被引文献8

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部